Sunventies Pharmaceuticals Private Limited
About Sunventies Pharmaceuticals Private Limited
Data last updated:
Sunventies Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It was incorporated on 17 May 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U46497TS2023PTC173129. Its GSTIN is 36ABKCS8488C1ZT (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vadepalli Shiva Praveen and Srinivas Vadepalli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14 – 193 Vivekananda Nagar, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.94 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.96 Lakh (net margin -19.7%) and EBITDA of -₹1.91 Lakh (EBITDA margin -19.2%).
Company details
Contact details
Sunventies Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address14 – 193 Vivekananda Nagar, Hyderabad, Telangana, India – 500055
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sunventies Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Sunventies Pharmaceuticals Private Limited, buy the company report.
Financials of Sunventies Pharmaceuticals Private Limited
FY 2025 filings availableSunventies Pharmaceuticals Private Limited reported revenue of ₹9.94 Lakh (up 266% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 266% in the latest year. EBITDA rose 63% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.91 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.96 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -19.2% | |
| Net Profit Margin | -19.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sunventies Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sunventies Pharmaceuticals Private Limited
Sunventies Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vadepalli Shiva Praveen Also directs: Skymac Pharmaceuticals (OPC) Private Limited | Director | 17 May 2023 | 3 Years 5 Months | Current |
| Srinivas Vadepalli | Director | 07 Sep 2024 | 2 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Sunventies Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunventies Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunventies Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABKCS8488C1ZT | Telangana | Active | 19 Jun 2023 |
To see the full GST registrations and return filing status of Sunventies Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sunventies Pharmaceuticals Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Srinivas Vadepalli ceased to be Director on 29 Sep 2024.
Frequently asked questions
Sunventies Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. It was incorporated on 17 May 2023 (3+ years old) and is registered under CIN U46497TS2023PTC173129.
Sunventies Pharmaceuticals has 2 current directors:
- Vadepalli Shiva Praveen - Director
- Srinivas Vadepalli - Director
The latest financial statements of Sunventies Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Sunventies Pharmaceuticals is 36ABKCS8488C1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Sunventies Pharmaceuticals is U46497TS2023PTC173129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunventies Pharmaceuticals was incorporated on 17 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srinivas Vadepalli ceased to be Director on 29 Sep 2024. Ganesh Narlakanti ceased to be Director on 09 Sep 2024. Srinivas Vadepalli was appointed as Director on 07 Sep 2024. Sunventies Pharmaceuticals has 4 board changes on record in total.
The registered office of Sunventies Pharmaceuticals is at 14 – 193 Vivekananda Nagar, Hyderabad, Telangana, India – 500055.
Sunventies Pharmaceuticals can be reached at its registered office: 14 – 193 Vivekananda Nagar, Hyderabad, Telangana, India – 500055.
Sunventies Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.